We are live on ! Find out more
CG

CFO4Life Group Portfolio holdings

AUM $656M
1-Year Est. Return 17.88%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+17.88%
3 Year Est. Return
+43.38%
5 Year Est. Return
+49.69%
10 Year Est. Return
AUM
$484M
AUM Growth
+$54.1M
Cap. Flow
+$16.5M
Cap. Flow %
3.41%
Top 10 Hldgs %
60.38%
Holding
167
New
25
Increased
85
Reduced
34
Closed
13

Sector Composition

Rank Sector Weight
1 Industrials 17.89%
2 Technology 10.81%
3 Consumer Staples 8.27%
4 Financials 6.07%
5 Consumer Discretionary 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYG icon
151
Lloyds Banking Group
LYG
$89.5B
$109K 0.02%
42,582
+1,073
+3% +$2.74K
PAGP icon
152
Plains GP Holdings
PAGP
$5.21B
$106K 0.02%
10,488
+125
+1% +$1.35K
COMS
153
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$50K 0.01%
661
BCLI
154
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$48K 0.01%
800
ARKK icon
155
ARK Innovation ETF
ARKK
$5.64B
-1,857
Closed -$205K
BABA icon
156
Alibaba
BABA
$293B
-1,379
Closed -$204K
BDX icon
157
Becton Dickinson
BDX
$45.6B
-1,091
Closed -$262K
BIDU icon
158
Baidu
BIDU
$37.7B
-1,303
Closed -$200K
CRL icon
159
Charles River Laboratories
CRL
$11.2B
-2,275
Closed -$939K
EW icon
160
Edwards Lifesciences
EW
$49.6B
-3,180
Closed -$360K
GRMN
161
Garmin
GRMN
$56.7B
-4,791
Closed -$745K
MDU icon
162
MDU Resources
MDU
$4.17B
-55,306
Closed -$624K
QRVO icon
163
Qorvo
QRVO
$7.99B
-3,431
Closed -$574K
YUM icon
164
Yum! Brands
YUM
$41.8B
-3,117
Closed -$381K
BIOL
165
DELISTED
Biolase, Inc.
BIOL
-13
Closed -$21K
ZIXI
166
DELISTED
Zix Corporation
ZIXI
-55,000
Closed -$389K
RPAI
167
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
-18,001
Closed -$232K

Similar funds

CFO4Life Group's Q4 2021 Portfolio in Review

As of Q4 2021, CFO4Life Group held 167 positions worth $484M, up 13% from $430M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

CFO4Life Group deployed $16.5M of net new capital in Q4 2021, opening 25 new positions and adding to 85 existing holdings. Its largest new stake was Gilead Sciences: 14,754 shares worth $1.07M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Lennox International, an estimated $1.17M trimmed.

  • CFO4Life Group's largest Q4 2021 buy was Gilead Sciences: 14,754 shares worth $1.07M.
  • CFO4Life Group added most to First Trust Smith Opportunistic Fixed Income ETF in Q4 2021, an estimated $2.66M increase.
  • CFO4Life Group's biggest Q4 2021 reduction was Lennox International, cutting an estimated $1.17M.
  • CFO4Life Group fully exited Charles River Laboratories in Q4 2021, selling an estimated $939K.
  • CFO4Life Group's ten largest holdings make up 60% of its $484M portfolio in Q4 2021.
  • CFO4Life Group opened 25 new positions and closed 13 in Q4 2021.
  • CFO4Life Group's portfolio value rose 13% quarter-over-quarter to $484M.

Based on CFO4Life Group's 13F filing for Q4 2021, filed 10 Feb 2022.